Last video

Posición de los trocares para cirugía laparoscópica y robótica de riñón y pélvica de acuerdo a la anatomía

View all videos

Week Article

  • Tivozanib in renal cell carcinoma: a new approach to previously treated disease

    Targeted therapies have been a mainstay of the renal cell carcinoma (RCC) treatment paradigm for the better part of two decades. Multikinase inhibitors of the vascular endothelial growth factor receptor tyrosine kinases (VEGF-TKIs) comprise nearly all targeted therapies in RCC, having been prospectively tested through large, multi-institutional phase III trials. ...

View all articles

About us

The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.

Read more

Last Tweets

Just in @KCA_Journal 👉🏻1/3rd patients with mRCC kidneycancer have bone mets. Scant data on development, prevention, prognosis and treatment of skeletal related events (SREs) in mRCC👉🏻Excellent systemic review by @PBarataMD @bilenma & team. @KidneyCancer


Not typical for an #oncologist to sift through @NatRevNeph so leading my friends towards this DEFINITIVE article on #kidneycancer biomarkers written from start to finish by @NazliDizman, a resident now at @YaleMedicine. Please have a look! @neerajaiims @DrChoueiri @kamkalantar

Load More...



You don't have permission to register